newsfilter
← Latest News
Business Wire·

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results

Q4 net sales from the eyecare and wound care segment grew 10% over the prior year with higher sales from the Avenova® physician dispensed and OTC channels, and from branded wound care products Sales and